Neurocrine Biosciences, Inc.
Head Quarters
12780 El Camino Real USWebsite
http://www.neurocrine.comIndustry
BiotechnologyEmployees
196Exchange
NASDAQNeurocrine Biosciences, Inc. operates as a product based biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale on January, 1992 and is headquartered in San Diego, CA.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 10 |
| Gross Margin (%) | 0.00% |
| Net Margin (%) | 0.00% |
| Returns | Stock |
| Sales | $0.00 |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$77.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 0.00 |
| EPS | -$2.00 |